International Journal of Innovation and Entrepreneurship

(ISSN: 2753-6297) Open Access Journal
Rss Feed:

Aims and Scope

International Journal of Innovation and Entrepreneurship (IJIE), ISSN: 2753-6297, is dedicated to publishing academic research and practical guidance on all aspects of innovation and entrepreneurship based on international evidence. The gap between innovation and entrepreneurship reflects the differences between being a scientist and being a businessperson. The knowledge and skillset for the two roles are closely related but substantially disparate. IJIE aims to fill this gap, smooth the knowledge transfer, and enhance the research impact.

Donate and Help to Develop our Journal!

The scopes of IJIE cover and bridge two broad fields. On the one hand, we publish scientific research of cutting-edge innovations in multiple fields such as engineering, physical science, medical science, and computer science. On the other hand, the journal provides a forum for innovators, entrepreneurs, educators, and policymakers to share successful (and unsuccessful) business case studies, economic policies, and education advances that can nurture innovation, entrepreneurship, and the transformation between them. We also welcome socio-economic articles on the impacts of innovation and entrepreneurship, such as inequality, mobility, sustainability, institutional quality, and cultural dynamics.

IJIE promotes open access publication to maximize the dissemination of latest scientific innovations and entrepreneurial insights.

Subject Fields

Physical Sciences & Engineering: This subject field covers both fundamental and applied research including but not limited to physics, chemistry, astronomy, materials science, mechanical engineering, chemical engineering, and electrical engineering.

Medical Sciences: This subject field covers biomedical, pre-clinical, and clinical research including but not limited to physiology, biochemistry, molecular biology, pharmacology, immunology, pathology, pathophysiology, surgery, internal medicine, obstetrics & gynecology, and pediatrics & otorhinolaryngology.

Computer Sciences: This subject field covers both theoretical and applied research including but not limited to theory of computation, data structures algorithms, programming, artificial intelligence, networks, cryptography, graphics visualization, image & sound processing, and software engineering.

Social Sciences: This subject field covers theoretical, empirical, and practical research on innovation and entrepreneurship, including but not limited to economics, management science, and sociology. The research can take the micro-level perspective (e.g., innovator, entrepreneur, educator) or the macro-level perspective (e.g., inequality, mobility, sustainability). It can focus on causality identification, decision-making, or policy-making.

Editors

Dr Peng Zhou
Editor-in-Chief
Cardiff Business School, Cardiff University, UK
Email: zhoup1@cardiff.ac.uk
Webpage: official personal

Dr Nikolaos Tzivanakis
Associate Editor
Institute for Global Prosperity, University College London, UK
Email: n.tzivanakis@ucl.ac.uk
Webpage: official personal

Dr Bing Gong
Associate Editor
University of Chinese Academy of Social Sciences, China
Email: bicegongbing@hotmail.com

Dr Mark Fields
Associate Editor
Circular Economy Technologist, Mitsubishi Chemical Group, UK
Email: mark.fields@m-chem.com

Dr Louisa Chard Dunmall
Associate Editor
Barts Cancer Institute, Queen Marry University of London, UK
Chief Technology Officer and Cofounder, VacV Biotherapeutics Ltd, UK
Email: l.chard@qmul.ac.uk
Webpage: official

Mr Clément Lavallard
Associate Editor
Founding Partner, Charcot Capital, Singapore
Email: clement.e.lavallard@gmail.com
Webpage: official

Dr Wei Yin
Associate Editor
School of Economics and Management, Southeast University, China
Email: yinwei_seu@seu.edu.cn
Webpage: official

Dr Feng Shi
Associate Editor
Venture Capital
Email: cardiff@studenthelpteam.net

Section Editors-in-Chief

Dr Yao Lu
Section Editor-in-Chief: Physical Sciences & Engineering
School of Physical and Chemical Sciences, Queen Marry University of London, UK
Email: yao.lu@qmul.ac.uk
Webpage: official

Dr Peng Liu
Section Editor-in-Chief: Medical Sciences
Barts Cancer Institute, Queen Marry University of London, UK
Email: p.liu@qmul.ac.uk
Webpage: official

Dr Tuanfeng Wang
Section Editor-in-Chief: Computer Sciences
Adobe Research (London), UK
Email: yangtwan@adobe.com
Webpage: official personal

Dr Bo Zhang
Section Editor-in-Chief: Social Sciences
School of Economics and Management, Beijing University of Chemical Technology, China
Email: bzhang@mail.buct.edu.cn
Webpage: official

Editorial Board Members

Ms Meng Li
University of Macao, Macao
Email: yb87529@um.edu.mo
Webpage

Ms Ying Zhang
Surrey Business School, Surrey University, UK
Email: y.y.zhang@surrey.ac.uk
Webpage: official

Submission Checklist

Please:

  1. Read the Aims and Scope to gain an overview and assess if your manuscript is suitable for this journal.
  2. Use the templates (MS Word, Latex) to prepare your manuscript.
  3. Make sure that issues about publication ethics, research ethics, copyright, authorship, figure formats, data and references format have been appropriately considered.
  4. Ensure that all authors have approved the content of the submitted manuscript.
  5. Authors are encouraged to add a biography (optional) to the submission and publish it.
  6. If accepted, please pay the Article Processing Charges (APCs) before your paper is published.

Types of Publication

Manuscripts submitted to IJIE should neither be published previously nor be under consideration for publication in another journal. IJIE publishes original research in three types:

  • Articles: Full-length research manuscripts. The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information.
  • Letters: Concise and timely reviews, updates, insights, critics, communications on the latest progress made in a given area of research.
  • Essays: Original research from emerging scientists (e.g., secondary school students, undergraduate students, postgraduate students). It provides an educational platform foremerging researchers to accumulate research experience and communicate innovative idea with leading scientists in the field.

The requirements of the three types of publication are different:

Type Wordcount Page Display References
Articles 2,500 6 4 30
Letters 1,000 2 1 10
Essays 2,500 6 4 30

Note that the wordcount and page limits here apply to the entire manuscript including the title, abstract, references etc.

Accepted File Formats

Authors are encouraged to use the MS Word template or LaTeX template to prepare their manuscript. Using the template file will substantially shorten the time to complete copy-editing and publication of accepted manuscripts. The total amount of data for all files must not exceed 120 MB. Accepted file formats are:

  • Microsoft Word: Manuscripts prepared in Microsoft Word must be converted into a single file before submission. When preparing manuscripts in Microsoft Word, we encourage you to use the Microsoft Word template. Please insert your displays (schemes, figures, etc.) in the main text after the paragraph of its first citation.
  • LaTeX: Manuscripts prepared in LaTeX must be collated into one ZIP folder (including all source files and images, so that the Editorial Office can recompile the submitted PDF). When preparing manuscripts in LaTeX, we encourage you to use the LaTeX template.
  • Supplementary files: May be any format, but it is recommended that you use common, non-proprietary formats where possible.

Disclaimer: Usage of these templates is exclusively intended for submission to the journal for peer-review, and strictly limited to this purpose and it cannot be used for posting online on preprint servers or other websites.

IJIE also accepts free format submission:

  • We do not have strict formatting requirements, but all manuscripts should consider containing the following sections: Author Information, Abstract, Keywords, Introduction, Materials & Methods, Results, Conclusions, Figures and Tables with Captions, Funding Information, Author Contributions, Conflict of Interest, and other Ethics Statements.
  • Your references may be in any style, provided that you use the consistent formatting throughout. It is essential to include author(s) name(s), journal or book title, article or chapter title (where required), year of publication, volume and issue (where appropriate) and pagination. DOI numbers (Digital Object Identifier) are not mandatory but highly encouraged. The bibliography software package EndNoteMendeleyReference Managerare recommended.
  • When your manuscript reaches the revision stage, you will be requested to format the manuscript according to the journal guidelines.

Submission Process

Manuscripts for IJIE should be submitted online. The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process. The submitting author must ensure that all eligible co-authors have been included in the author listand that they have all read and approved the submitted version of the manuscript.

Preparing the Manuscript

Front Matter

These components should appear in the front matter of all manuscript types:

  • Title: The title of your manuscript should be concise, specific and relevant. It should identify if the study reports (human or animal) trial data, or is a systematic review, meta-analysis or replication study. When gene or protein names are included, the abbreviated name rather than full name should be used. Please do not include abbreviated or short forms of the title, such as a running title or head. These will be removed by our Editorial Office.
  • Author List and Affiliations: Authors' full first and last names must be provided. The initials of any middle names can be added. The PubMed/MEDLINE standard format is used for affiliations: complete address information including city, zip code, state/province, and country. At least one author should be designated as corresponding author, and his or her email address and other details should be included at the end of the affiliation section.
  • Abstract: The abstract should be a total of about 200 words maximum. The abstract should be a single paragraph and should follow the style of structured abstracts, but without headings: 1) Background: Place the question addressed in a broad context and highlight the purpose of the study; 2) Methods: Describe briefly the main methods or treatments applied. Include any relevant preregistration numbers, and species and strains of any animals used. 3) Results: Summarize the article's main findings; and 4) Conclusion: Indicate the main conclusions or interpretations. The abstract should be an objective representation of the article: it must not contain results which are not presented and substantiated in the main text and should not exaggerate the main conclusions.
  • Keywords: Three to ten pertinent keywords need to be added after the abstract. We recommend that the keywords are specific to the article, yet reasonably common within the subject discipline.

Sections

There is no rigid requirement on the structure of manuscript sections, but a conventional research paper has the following sections:

  • Introduction: The introduction should briefly place the study in a broad context and highlight why it is important. It should define the purpose of the work and its significance, including specific hypotheses being tested. The current state of the research field should be reviewed carefully and key publications cited. Please highlight controversial and diverging hypotheses when necessary. Finally, briefly mention the main aim of the work and highlight the main conclusions. Keep the introduction comprehensible to scientists working outside the topic of the paper.
  • Methods: It should be described with sufficient detail to allow others to replicate and build on published results. New methods and protocols should be described in detail while well-established methods can be briefly described and appropriately cited. Give the name and version of any software used and make clear whether computer code used is available. Include any pre-registration codes.
  • Results: Provide a concise and precise description of the experimental results, their interpretation as well as the experimental conclusions that can be drawn.
  • Discussions: Authors should discuss the results and how they can be interpreted in perspective of previous studies and of the working hypotheses. The findings and their implications should be discussed in the broadest context possible and limitations of the work highlighted. Future research directions may also be mentioned. This section may be combined with Results.
  • Conclusions: This section is not mandatory but can be added to the manuscript if the discussion is unusually long or complex.
  • Patents: This section is not mandatory but may be added if there are patents resulting from the work reported in this manuscript.

Back Matter

The back matter compiles data and information related to the manuscript:

  • Supplementary Materials: Describe any supplementary material published online alongside the manuscript (figure, tables, video, spreadsheets, etc.). Please indicate the name and title of each element as follows Figure S1: title, Table S1: title, etc.
  • Funding: All sources of funding of the study should be disclosed. Clearly indicate grants that you have received in support of your research work and if you received funds to cover publication costs. Note that some funders will not refund article processing charges (APC) if the funder and grant number are not clearly and correctly identified in the paper. Funding information can be entered separately into the submission system by the authors during submission of their manuscript. Such funding information, if available, will be deposited to FundRef if the manuscript is finally published.
    Please add: “This research received no external funding” or “This research was funded by [name of funder] grant number [xxx]” and “The APC was funded by [XXX]” in this section. Check carefully that the details given are accurate and use the standard spelling of funding agency names at https://search.crossref.org/funding, any errors may affect your future funding.
  • Acknowledgments: In this section you can acknowledge any support given which is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).
  • Author Contributions: Each author is expected to have made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; or have drafted the work or substantively revised it; AND has approved the submitted version (and version substantially edited by journal staff that involves the author’s contribution to the study); AND agrees to be personally accountable for the author’s own contributions and for ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and documented in the literature.
    For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used "Conceptualization, X.X. and Y.Y.; Methodology, X.X.; Software, X.X.; Validation, X.X., Y.Y. and Z.Z.; Formal Analysis, X.X.; Investigation, X.X.; Resources, X.X.; Data Curation, X.X.; Writing – Original Draft Preparation, X.X.; Writing – Review & Editing, X.X.; Visualization, X.X.; Supervision, X.X.; Project Administration, X.X.; Funding Acquisition, Y.Y.”, please turn to the CRediT taxonomy for the term explanation. Authorship must include and be limited to those who have contributed substantially to the work.
  • Data Availability Statement: In this section, please provide details regarding where data supporting reported results can be found, including links to publicly archived datasets analyzed or generated during the study. You might choose to exclude this statement if the study did not report any data.
  • Conflicts of Interest: Authors must identify and declare any personal circumstances or interest that may be perceived as influencing the representation or interpretation of reported research results. If there is no conflict of interest, please state "The authors declare no conflict of interest." Any role of the funding sponsors in the choice of research project; design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results must be declared in this section. IJIE does not publish studies funded partially or fully by the tobacco industry. Any projects funded by industry must pay special attention to the full declaration of funder involvement. If there is no role, please state “The sponsors had no role in the design, execution, interpretation, or writing of the study”.
  • References: References must be numbered in order of appearance in the text (including table captions and figure legends) and listed individually at the end of the manuscript. We recommend preparing the references with a bibliography software package, such as EndNote, ReferenceManager or Zotero to avoid typing mistakes and duplicated references. We encourage citations to data, computer code and other citable research material.
  • Citations and References in Supplementary files are permitted provided that they also appear in the main text and in the reference list.

The reference list should include the full title, as recommended by the Chicago style guide.

Preparing Figures, Schemes, and Tables

  • File for Figures and Schemes must be provided during submission in a single zip archive and at a sufficiently high resolution (minimum 1000 pixels width/height, or a resolution of 300 dpi or higher). Common formats are accepted, however, TIFF, JPEG, EPS and PDF are preferred.
  • IJIE can publish multimedia files in articles or as supplementary materials. Please contact the editorial office for further information.
  • All Figures, Schemes and Tables should be inserted into the main text close to their first citation and must be numbered following their number of appearance (Figure 1, Scheme I, Figure 2, Scheme II, Table 1, etc.).
  • All Figures, Schemes and Tables should have a short explanatory title and caption.
  • All table columns should have an explanatory heading. To facilitate the copy-editing of larger tables, smaller fonts may be used, but no less than 8 pt. in size. Authors should use the Table option of Microsoft Word to create tables.
  • Authors are encouraged to prepare figures and schemes in color (RGB at 8-bit per channel). There is no additional cost for publishing full color graphics.

Preparing Supplementary Materials, Data Deposit, and Software Source Code

IJIE is committed to supporting open scientific exchange and enabling our authors to achieve best practices in sharing and archiving research data. We encourage all authors of articles published in IJIE to share their research data. Individual journal guidelines can be found at the journal ‘Instructions for Authors’ page. Data sharing policies concern the minimal dataset that supports the central findings of a published study. Generated data should be publicly available and cited in accordance with journal guidelines.

Where ethical, legal or privacy issues are present, data should not be shared. The authors should make any limitations clear in the Data Availability Statement upon submission. Authors should ensure that data shared are in accordance with consent provided by participants on the use of confidential data.

Data Availability Statements provide details regarding where data supporting reported results can be found, including links to publicly archived datasets analyzed or generated during the study.

Below are suggested Data Availability Statements:

  • Data available in a publicly accessible repository. The data presented in this study are openly available in [repository name e.g., FigShare] at [doi], reference number [reference number].
  • Data available in a publicly accessible repository that does not issue DOIs
    Publicly available datasets were analyzed in this study. This data can be found here: [link/accession number]
  • Data available on request due to restrictions eg privacy or ethical. The data presented in this study are available on request from the corresponding author. The data are not publicly available due to [insert reason here]
  • 3rd Party Data. Restrictions apply to the availability of these data. Data was obtained from [third party] and are available [from the authors / at URL] with the permission of [third party].
  • Data sharing not applicable. No new data were created or analyzed in this study. Data sharing is not applicable to this article.
  • Data is contained within the article or supplementary material. The data presented in this study are available in [insert article or supplementary material here]
  • [dataset] Authors. Year. Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g., DOI).
  • New nucleic acid sequencesmust be deposited in one of the following databases: GenBank, EMBL, or DDBJ. Sequences should be submitted to only one database.
  • New high throughput sequencing (HTS) datasets(RNA-seq, ChIP-Seq, degradome analysis, …) must be deposited either in the GEO database or in the NCBI’s Sequence Read Archive (SRA).
  • New microarray datamust be deposited either in the GEOor the ArrayExpressdatabases.The "Minimal Information About a Microarray Experiment" (MIAME) guidelines published by the Microarray Gene Expression Data Society must be followed.
  • New protein sequencesobtained by protein sequencing must be submitted to UniProt (submission tool SPIN). Annotated protein structure and its reference sequence must be submitted to RCSB of Protein Data Bank.

All sequence names and the accession numbers provided by the databases must be provided in the Methods section of the article.

Methods used to generate the proteomics data should be described in detail and we encourage authors to adhere to the "Minimum Information About a Proteomics Experiment". All generated mass spectrometry raw data must be deposited in the appropriate public database such as ProteomeXchange, PRIDE or jPOST. At the time of submission, please include all relevant information in the materials and methods section, such as repository where the data was submitted and link, data set identifier, username and password needed to access the data.

Cover Letter

A cover letter is optional. If included, it should be concise and explain why the content of the paper is significant, placing the findings in the context of existing work. Application for discount and waiver of APC can also be added on the cover letter upon submission.

Author Biography

Authors are encouraged to add a biography (maximum 150 words) to the submission and publish it. This should be a single paragraph and should contain the following points:

  1. Authors’ full names followed by current positions;
  2. Education background including institution information and year of graduation (type and level of degree received);
  3. Work experience;
  4. Current and previous research interests;
  5. Memberships of professional societies and awards received.

Editorial Procedures

Initial Checks

All submitted manuscripts received by the Editorial Office will be checked by a professional in-house Managing Editor to determine whether they are properly prepared and whether they follow the ethical policies of the journal, including those for human and animal experimentation. Manuscripts that do not fit the journal's ethics policy or do not meet the standards of the journal will be rejected before peer-review. Manuscripts that are not properly prepared will be returned to the authors for revision and resubmission. After these checks, the Managing Editor will consult the journals’ Editor-in-Chief or Associate Editors to determine whether the manuscript fits the scope of the journal and whether it is scientifically sound. No judgment on the potential impact of the work will be made at this stage. Reject decisions at this stage will be verified by the Editor-in-Chief.

Peer-Review

Once a manuscript passes the initial checks, it will be assigned to at least two independent experts for peer-review. A single-blind review is applied, where authors' identities are known to reviewers. Peer review comments are confidential and will only be disclosed with the express agreement of the reviewer.

In the case of regular submissions, in-house assistant editors will invite experts, including recommendations by an academic editor. These experts may also include Editorial Board Members and Guest Editors of the journal. Potential reviewers suggested by the authors may also be considered. Reviewers should not have published with any of the co-authors during the past five years and should not currently work or collaborate with any of the institutions of the co-authors of the submitted manuscript.

Optional Open Peer-Review

The journal operates optional open peer-review: Authors are given the option for all review reports and editorial decisions to be published alongside their manuscript. In addition, reviewers can sign their review, i.e., identify themselves in the published review reports. Authors can alter their choice for open review at any time before publication, but once the paper has been published changes will only be made at the discretion of the Publisher and Editor-in-Chief. We encourage authors to take advantage of this opportunity as proof of the rigorous process employed in publishing their research. To guarantee impartial refereeing, the names of referees will be revealed only if the referees agree to do so, and after a paper has been accepted for publication.

Editorial Decision and Revision

All the articles, letters, and essays published in IJIE go through the peer-review process and receive at least two reviews. The in-house editor will communicate the decision of the academic editor, which will be one of the following:

  • Accept after Minor Revisions:
    The paper is in principle accepted after revision based on the reviewer’s comments. Authors are given five days for minor revisions.
  • Reconsider after Major Revisions:
    The acceptance of the manuscript would depend on the revisions. The author needs to provide a point by point response or provide a rebuttal if some of the reviewer’s comments cannot be revised. Usually, only one round of major revisions is allowed. Authors will be asked to resubmit the revised paper within a suitable time frame, and the revised version will be returned to the reviewer for further comments.
  • Reject and Encourage Resubmission:
    If additional experiments are needed to support the conclusions, the manuscript will be rejected and the authors will be encouraged to re-submit the paper once further experiments have been conducted.
  • Reject:
    The article has serious flaws, and/or makes no original significant contribution. No offer of resubmission to the journal is provided.

All reviewer comments should be responded to in a point-by-point fashion. Where the authors disagree with a reviewer, they must provide a clear response.

Author Appeals

Authors may appeal a rejection by sending an e-mail to the Editorial Office of the journal. The appeal must provide a detailed justification, including point-by-point responses to the reviewers' and/or Editor's comments. The Managing Editor of the journal will forward the manuscript and related information (including the identities of the referees) to the Editor-in-Chief, Associate Editor, or Editorial Board member. The academic Editor being consulted will be asked to give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage is final and cannot be reversed.

In the case of a special issue, the Managing Editor of the journal will forward the manuscript and related information (including the identities of the referees) to the Editor-in-Chief who will be asked to give an advisory recommendation on the manuscript and may recommend acceptance, further peer-review, or uphold the original rejection decision. A reject decision at this stage will be final and cannot be reversed.

Production and Publication

Once accepted, the manuscript will undergo professional copy-editing, English editing, proofreading by the authors, final corrections, pagination, and, publication on the website.

Research Ethics

Research Involving Human Subjects

When reporting on research that involves human subjects, human material, human tissues, or human data, authors must declare that the investigations were carried out following the rules of the Declaration of Helsinki of 1975. According to point 23 of this declaration, an approval from the local institutional review board (IRB) or other appropriate ethics committee must be obtained before undertaking the research to confirm the study meets national and international guidelines. As a minimum, a statement including the project identification code, date of approval, and name of the ethics committee or institutional review board must be stated in Section ‘Institutional Review Board Statement’ of the article.

Example of an ethical statement: "All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of XXX (Project identification code)."

For non-interventional studies (e.g. surveys, questionnaires, social media research), all participants must be fully informed if the anonymity is assured, why the research is being conducted, how their data will be used and if there are any risks associated. As with all research involving humans, ethical approval from an appropriate ethics committee must be obtained prior to conducting the study. If ethical approval is not required, authors must either provide an exemption from the ethics committee or are encouraged to cite the local or national legislation that indicates ethics approval is not required for this type of study. Where a study has been granted exemption, the name of the ethics committee which provided this should be stated in Section ‘Institutional Review Board Statement’ with a full explanation regarding why ethical approval was not required.

A written informed consent for publication must be obtained from participating patients. Data relating to individual participants must be described in detail, but private information identifying participants need not be included unless the identifiable materials are of relevance to the research (for example, photographs of participants’ faces that show a particular symptom). Patients’ initials or other personal identifiers must not appear in any images. For manuscripts that include any case details, personal information, and/or images of patients, authors must obtain signed informed consent for publication from patients (or their relatives/guardians) before submission. Patient details must be anonymized as far as possible, e.g., do not mention specific age, ethnicity, or occupation where they are not relevant to the conclusions. Editors reserve the right to reject any submission that does not meet these requirements. The journal reserves the right to ask authors to provide signed forms if necessary.

If the study reports research involving vulnerable groups, an additional check may be performed. The submitted manuscript will be scrutinized by the editorial office and upon request, documentary evidence (blank consent forms and any related discussion documents from the ethics board) must be supplied. Additionally, when studies describe groups by race, ethnicity, gender, disability, disease, etc., explanation regarding why such categorization was needed must be clearly stated in the article.

Research Involving Animals

The editors will require that the benefits potentially derived from any research causing harm to animals are significant in relation to any cost endured by animals, and that procedures followed are unlikely to cause offense to the majority of readers. Authors should particularly ensure that their research complies with the commonly-accepted '3Rs':

  • Replacement of animals by alternatives wherever possible,
  • Reduction in number of animals used, and
  • Refinement of experimental conditions and procedures to minimize the harm to animals.

For further guidance authors should refer to the Code of Practice for the Housing and Care of Animals Used in Scientific Procedures, American Association for Laboratory Animal Science or European Animal Research Association.

If national legislation requires it, studies involving vertebrates or higher invertebrates must only be carried out after obtaining approval from the appropriate ethics committee. As a minimum, the project identification code, date of approval and name of the ethics committee or institutional review board should be stated in Section ‘Institutional Review Board Statement’. Research procedures must be carried out in accordance with national and institutional regulations. Statements on animal welfare should confirm that the study complied with all relevant legislation. Clinical studies involving animals and interventions outside of routine care require ethics committee oversight as per the American Veterinary Medical Association. If the study involved client-owned animals, informed client consent must be obtained and certified in the manuscript report of the research. Owners must be fully informed if there are any risks associated with the procedures and that the research will be published. If available, a high standard of veterinary care must be provided. Authors are responsible for correctness of the statements provided in the manuscript.

If ethical approval is not required by national laws, authors must provide an exemption from the ethics committee, if one is available. Where a study has been granted exemption, the name of the ethics committee that provided this should be stated in Section ‘Institutional Review Board Statement’ with a full explanation on why the ethical approval was not required.

If no animal ethics committee is available to review applications, authors should be aware that the ethics of their research will be evaluated by reviewers and editors. Authors should provide a statement justifying the work from an ethical perspective, using the same utilitarian framework that is used by ethics committees. Authors may be asked to provide this even if they have received ethical approval.

IJIE endorses the ARRIVE guidelines for reporting experiments using live animals. Authors and reviewers must use the ARRIVE guidelines as a checklist. Editors reserve the right to ask for the checklist and to reject submissions that do not adhere to these guidelines, to reject submissions based on ethical or animal welfare concerns or if the procedure described does not appear to be justified by the value of the work presented.

Research Involving Cell Lines

Methods sections reporting on research with cell lines should state the origin of any cell lines. For established cell lines the provenance should be stated and references must also be given to either a published paper or to a commercial source. If previously unpublished de novo cell lines were used, including those gifted from another laboratory, details of institutional review board or ethics committee approval must be given, and confirmation of written informed consent must be provided if the line is of human origin. An example of Ethical Statements:

The HCT116 cell line was obtained from XXXX. The MLH1+ cell line was provided by XXXXX, Ltd. The DLD-1 cell line was obtained from Dr. XXXX. The DR-GFP and SA-GFP reporter plasmids were obtained from Dr. XXX and the Rad51K133A expression vector was obtained from Dr. XXXX.

Research Involving Plants

Experimental research on plants (either cultivated or wild) including collection of plant material, must comply with institutional, national, or international guidelines. We recommend that authors comply with the Convention on Biological Diversity and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

For each submitted manuscript supporting genetic information and origin must be provided. For research manuscripts involving rare and non-model plants (other than, e.g., Arabidopsis thaliana, Nicotiana benthamiana, Oryza sativa, or many other typical model plants), voucher specimens must be deposited in an accessible herbarium or museum. Vouchers may be requested for review by future investigators to verify the identity of the material used in the study (especially if taxonomic rearrangements occur in the future). They should include details of the populations sampled on the site of collection (GPS coordinates), date of collection, and document the part(s) used in the study where appropriate. For rare, threatened or endangered species this can be waived but it is necessary for the author to describe this in the cover letter.

Editors reserve the rights to reject any submission that does not meet these requirements. An example of Ethical Statements:

Torenia fournieri plants were used in this study. White-flowered Crown White (CrW) and violet-flowered Crown Violet (CrV) cultivars selected from ‘Crown Mix’ (XXX Company, City, Country) were kindly provided by Dr. XXX (XXX Institute, City, Country).

Arabidopis mutant lines (SALKxxxx, SAILxxxx,…) were kindly provided by Dr. XXX , institute, city, country).

Clinical Trials Registration

Registration

IJIE follows the International Committee of Medical Journal Editors (ICMJE) guidelines which require and recommend registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication.

Purely observational studies do not require registration. A clinical trial not only refers to studies that take place in a hospital or involve pharmaceuticals, but also refer to all studies which involve participant randomization and group classification in the context of the intervention under assessment.

Authors are strongly encouraged to pre-register clinical trials with an international clinical trials register and cite a reference to the registration in the Methods section. Suitable databases include clinicaltrials.govthe EU Clinical Trials Register and those listed by the World Health Organisation International Clinical Trials Registry Platform.

Approval to conduct a study from an independent local, regional, or national review body is not equivalent to prospective clinical trial registration. IJIE reserves the right to decline any paper without trial registration for further peer-review. However, if the study protocol has been published before the enrolment, the registration can be waived with correct citation of the published protocol.

CONSORT Statement

IJIE requires a completed CONSORT 2010 checklist and flow diagram as a condition of submission when reporting the results of a randomized trial. Templates for these can be found here or on the CONSORT website (http://www.consort-statement.org) which also describes several CONSORT checklist extensions for different designs and types of data beyond two group parallel trials. At minimum, your article should report the content addressed by each item of the checklist.

Sex and Gender in Research

We encourage our authors to follow the ‘Sex and Gender Equity in Research – SAGER – guidelines’ and to include sex and gender considerations where relevant. Authors should use the terms sex (biological attribute) and gender (shaped by social and cultural circumstances) carefully in order to avoid confusing both terms. Article titles and/or abstracts should indicate clearly what sex(es) the study applies to. Authors should also describe in the background, whether sex and/or gender differences may be expected; report how sex and/or gender were accounted for in the design of the study; provide disaggregated data by sex and/or gender, where appropriate; and discuss respective results. If a sex and/or gender analysis was not conducted, the rationale should be given in the Discussion. We suggest that our authors consult the full guidelines before submission.

Borders and Territories

Potential disputes over borders and territories may have particular relevance for authors in describing their research or in an author or editor correspondence address, and should be respected. Content decisions are an editorial matter and where there is a potential or perceived dispute or complaint, the editorial team will attempt to find a resolution that satisfies parties involved.

IJIE stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Publication Ethics Statement

The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of IJIE take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy.

Authors wishing to publish their papers in IJIE must abide to the following:

  • Any facts that might be perceived as a possible conflict of interest of the author(s) must be disclosed in the paper prior to submission.
  • Authors should accurately present their research findings and include an objective discussion of the significance of their findings.
  • Data and methods used in the research need to be presented in sufficient detail in the paper, so that other researchers can replicate the work.
  • Raw data should preferably be publicly deposited by the authors before submission of their manuscript. Authors need to at least have the raw data readily available for presentation to the referees and the editors of the journal, if requested. Authors need to ensure appropriate measures are taken so that raw data is retained in full for a reasonable time after publication.
  • Simultaneous submission of manuscripts to more than one journal is not tolerated.
  • The journal accepts exact translations of previously published work.
  • If errors and inaccuracies are found by the authors after publication of their paper, they need to be promptly communicated to the editors of this journal so that appropriate actions can be taken.
  • Your manuscript should not contain any information that has already been published. If you include already published figures or images, please obtain the necessary permission from the copyright holder to publish under the CC-BY license.
  • Plagiarism, data fabrication and image manipulation are not tolerated.
    • Plagiarism is not acceptable in IJIE submissions. Plagiarism includes copying text, ideas, images, or data from another source, even from your own publications, without giving any credit to the original source. Reuse of text that is copied from another source must be between quotes and the original source must be cited. If a study's design or the manuscript's structure or language has been inspired by previous works, these works must be explicitly cited. All submissions are checked for plagiarism using the industry standard software iThenticate. If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, an investigation will take place and action taken in accordance with our policies.
    • Image files must not be manipulated or adjusted in any way that could lead to misinterpretation of the information provided by the original image. Irregular manipulation includes: 1) introduction, enhancement, moving, or removing features from the original image; 2) grouping of images that should obviously be presented separately (e.g., from different parts of the same gel, or from different gels); or 3) modifying the contrast, brightness or color balance to obscure, eliminate or enhance some information. If irregular image manipulation is identified and confirmed during the peer review process, we may reject the manuscript. If irregular image manipulation is identified and confirmed after publication, we may correct or retract the paper.

Our in-house editors will investigate any allegations of publication misconduct and may contact the authors' institutions or funders if necessary. If evidence of misconduct is found, appropriate action will be taken to correct or retract the publication. Authors are expected to comply with the best ethical publication practices when publishing with IJIE.

Citation Policy

Authors should ensure that where material is taken from other sources (including their own published writing) the source is clearly cited and that where appropriate permission is obtained.

Authors should not engage in excessive self-citation of their own work.

Authors should not copy references from other publications if they have not read the cited work.

Authors should not preferentially cite their own or their friends’, peers’, or institution’s publications.

Authors should not cite advertisements or advertorial material.

In accordance with COPE guidelines, we expect that “original wording taken directly from publications by other researchers should appear in quotation marks with the appropriate citations.” This condition also applies to an author’s own work. COPE have produced a discussion document on citation manipulation with recommendations for best practice.

Editorial Independence

Lack of Interference With Editorial Decisions

Editorial independence is of utmost importance and IJIE does not interfere with editorial decisions. All articles published by IJIE are peer reviewed and assessed by our independent editorial boards, and IJIE staff are not involved in decisions to accept manuscripts. When making an editorial decision, we expect the academic editor to make their decision based only upon:

  • The suitability of selected reviewers;
  • Adequacy of reviewer comments and author response;
  • Overall scientific quality of the paper.

In all of our journals, in every aspect of operation, IJIE policies are informed by the mission to make science and research findings open and accessible as widely and rapidly as possible.

Editors and Editorial Staff as Authors

Editorial staff or editors shall not be involved in processing their own academic work. Submissions authored by editorial staff/editors will be assigned to at least two independent outside reviewers. Decisions will be made by other Editorial Board Members who do not have a conflict of interest with the author. Journal staff are not involved in the processing of their own work submitted to IJIE.

Conflict of Interests

According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.”

All authors must disclose all relationships or interests that could inappropriately influence or bias their work. Examples of potential conflicts of interest include but are not limited to financial interests (such as membership, employment, consultancies, stocks/shares ownership, honoraria, grants or other funding, paid expert testimonies and patent-licensing arrangements) and non-financial interests (such as personal or professional relationships, affiliations, personal beliefs).

Authors can disclose potential conflicts of interest via the online submission system during the submission process. The corresponding author must include a summary statement in the manuscript in a separate section “Conflicts of Interest” placed just before the reference list. The statement should reflect all the collected potential conflict of interest disclosures in the form.

See below for examples of disclosures:

Conflicts of Interest: Author A has received research grants from Company A. Author B has received a speaker honorarium from Company X and owns stocks in Company Y. Author C has been involved as a consultant and expert witness in Company Z. Author D is the inventor of patent X.

If no conflicts exist, the authors should state:

Conflicts of Interest: The authors declare no conflicts of interest.

Promoting Equity, Diversity and Inclusiveness

Our Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, sexual orientation, age, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of IJIE are to uphold these principles in high regard.

Open Access and Article Processing Charge

All articles published in IJIE (ISSN: 2753-6297) are published in Gold Open Access. An article processing charge (APC) applies to papers accepted after peer review. The APC is to cover the costs of peer review, copyediting, typesetting, long-term archiving, and journal management. Note that many national and private research funding organizations and universities explicitly cover APCs for articles resulting from funded research projects.

We accept payment in Great Britain Pounds (GBP), Euros (EUR), Swiss Francs (CHF), US Dollars (USD), Canadian Dollars (CAD), Japanese Yen (JPY), Hong Kong Dollars (HKD). The APCs of different types of publications are listed below:

 

Article

Letter

Essay

GBP

2,000

1,800

2,000

EUR

2,400

2,200

2,400

CHF

2,350

2,100

2,350

USD

2,500

2,200

2,500

CAD

3,200

2,850

3,200

JPY

330,000

300,000

330,000

HKD

19,500

17,500

19,500

Local VAT or Sales Tax will be added if applicable.

Discounts and Waivers

APC discounts and waivers are available for authors with financial difficulties or for other justifiable reasons. IJIE is committed to supporting the transition of all research to fully open access, therefore we regularly offer APC discounts and waivers. On average, we waive approximately 25%-27% of our content every year. Please apply for discount/waiver of APC in the cover letter, detailing the reasons, justifications, and evidence.